Skip to content

Open-label effects in skin picking disorder

Open-label effects in skin picking disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035003
Enrollment
100
Registered
2024-09-20
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatillomania / skin picking disorder (code ICD 11: 6B25.1 Excoriation disorder)

Interventions

Group 1: OLP-group: intake of placebo capsules (capsules filled with starch). Duration: 2 weeks, daily intake (in the morning) planned. Group 2: Control: No intake of capsules

Sponsors

Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Skin picking symptomatic

Exclusion criteria

Exclusion criteria: Severe skin diseases and severe psychological comorbidities (e.g. psychotic disorder, substance dependence).

Design outcomes

Primary

MeasureTime frame
Questionnaire to record skin picking symptoms and emotional state (administered before and after the two groups, i.e. 4 times in total): - Skin Picking Revised Scale (SPS-R, Gallinat et al., 2016) - Brief Symptom Inventory (BSI-18; Franke, G. H., 2000) - Perceived Stress Questionnaire (PSQ-20; Fliege, H et al., 2009) - Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004)

Secondary

MeasureTime frame
Daily app rating (during capsule intake and control phase) with information on how you felt (How long did you manipulate your skin today? How intense was the urge to manipulate your skin today? How stressed were you today?)

Countries

Austria, Germany, Switzerland

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.at+43 316 380 5086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026